The Michael J. Fox Foundation has evolved its Parkinson’s Progression Markers Initiative into the Parkinson’s Precision Medicine Initiative, focusing on tailored treatments based on individual biological differences in patients. With over 4,200 clinical participants and more than 47,000 online contributors, this initiative aims to innovate clinical trial designs and ensure treatments align with specific patient profiles, all while advancing research on Parkinson’s disease. The Michael J. Fox Foundation has evolved its Parkinson’s Progression Markers Initiative into the Parkinson’s Precision Medicine Initiative, focusing on tailored treatments based on individual biological differences in patients. With over 4,200 clinical participants and more than 47,000 online contributors, this initiative aims to innovate clinical trial designs and ensure treatments align with specific patient profiles, all while advancing research on Parkinson’s disease.
Trending
- UAE honours flydubai pilot Smit Machchhar who fought off co-pilot’s attack to save passengers
- BP Singh death: Shivaji Satam recalls mentor and friend; hails his dedication to CID
- Brothers Get 30-Year Sentences: New York court jails Alexander trio; 12 victims describe trauma
- ‘Brings the worst out of us’: Ex-cricketer on trolling after Ind’s NZ demolition
- Watch: High tides, uprooted trees as Cyclone Arnab makes landfall along Andhra coast
- Bradley Cooper’s family home bought for $38,000 now worth $700,000
- ‘Raped by Rohingya refugees’: Landlord finds woman held captive for 5 months
- Amazon updates AI usage rules for engineers in new memo
Michael J. Fox’s Parkinson’s study data downloaded over 50 million times
By
Add A Comment